Literature DB >> 9748110

Conditioned inhibition of antibody response and CD4 positive cells.

F Napolitano1, G De Rosa, F Grasso, G Migliori, A Bordi.   

Abstract

Animals were assigned to three experimental groups, conditioned (cyclophosphamide-glucose treatment; C group), non-conditioned (cyclophosphamide-commercial pellet treatment; NC group) and placebo (saline solution-glucose treatment; P group). The three groups were injected intraperitoneally (i.p.) with sheep red blood cells. An hemagglutination assay according to standard procedures was performed along with the flow cytofluorometric analysis of leukocyte surface antigens CD4, CD8 and CD45. C group consumed less food on Days 3 and 6 than on Day 0, NC animals showed no changes in food consumption throughout the experimental period, whereas an increasing trend was observed for P animals. The proportion of T lymphocytes expressing CD8 and CD45 did not differ significantly among C, NC and P groups. Group C showed the lowest proportion of T lymphocytes bearing CD4, whereas Group P displayed the highest. The antibody response was lower in the Group C than in the groups NC and P. We conclude that, although the mechanisms by which humoral conditioned immunosuppression occurs in mice is still unknown, a reduced T helper-mediated activation of B-cells may play an important role in producing conditioned humoral response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748110     DOI: 10.1016/s0031-9384(98)00093-6

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  2 in total

1.  A comparative study on the effect of BCG-PSN and thymopeptides on T-lymphocyte subsets of normal and immunosuppressed mice.

Authors:  Yunhua Deng; Yingling Chen; Xingping Chen; Yongxi Li; Liyi Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

Review 2.  Inflammatory breast diseases during lactation: health effects on the newborn-a literature review.

Authors:  Achim Wöckel; Michael Abou-Dakn; Anna Beggel; Petra Arck
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.